Abiopharma

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-08-28 <b>AccNo:</b> 0001839882-26-042214 <b>Size:</b> 294 KB

Clinical trial NCT07768371: status: NOT_YET_RECRUITING → RECRUITING.

Clinical trial NCT05923073: completion date: 2028-07-12 → 2028-08-14.

Clinical trial NCT05438043: completion date: 2029-12-31 → 2029-01-31.

Clinical trial NCT05757869 updates: 1. completion date: 2026-10-31 → 2026-12-08 2. primary completion date: 2026-10-31 → 2026-12-08

Clinical trial NCT07612878 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-07-31 → 2026-08-06

Clinical trial NCT07502495 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment: 60 → 64 participants 3. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT07191873 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-08-01 → 2026-08-25

Clinical trial NCT03331250 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-02-01 → 2023-05-23 3. primary completion date: 2023-07-21 → 2022-03-31

Financial Statements and Related Announcement: Full Yearly Results

Clinical trial NCT07488884 updates: 1. status: NOT_YET_RECRUITING → WITHDRAWN 2. start date: 2026-06-01 → 2026-09-01 3. enrollment: 30 → 0 participants 4. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT07534592 updates: 1. completion date: 2026-08-28 → 2026-10-01 2. primary completion date: 2026-08-28 → 2026-10-01

Clinical trial NCT07599761 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. start date: 2026-05-05 → 2026-05-07 3. completion date: 2026-07-01 → 2026-09-01 4. primary completion date: 2026-07-01 → 2026-09-01 5. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT07218666: start date: 2026-07-01 → 2026-08-19.

Clinical trial NCT07276815 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-08-31 → 2026-08-06